SCHEMBL6940855

SCHEMBL6940855

CC(C)(C)C(=O)CN1C(=O)CN=C(c2ccccc2)c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.64
KDM4E B2RXH2 1/20 0.64
NPSR1 Q6W5P4 4/20 0.62
GAA P10253 2/20 0.62
HTT P42858 1/20 0.62
GPR55 Q9Y2T6 1/20 0.62
MAPT P10636 5/20 0.61
ALDH1A1 P00352 3/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2C19 P33261 1/20 0.61
RECQL P46063 1/20 0.61
HDAC3 O15379 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
HSD17B10 Q99714 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
TP53 P04637 3/20 0.57
CCKBR P32239 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6934431 0.92 SMN1; SMN2 (0.55) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL6940247 0.87 NPSR1 (0.68) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL12143205 0.86 SMN1; SMN2 (0.67) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL8672792 0.86 SMN1; SMN2 (0.67) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL8670183 0.85 SMN1; SMN2 (0.60) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL4992176 0.84 CYP1A2 (0.59) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL7945100 0.84 SMN1; SMN2 (0.64) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL9089011 0.83 SMN1; SMN2 (0.63) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL8546479 0.82 KDM4E (0.46) SMN1; SMN2KDM4ENPSR1GAAHTT
SCHEMBL8548821 0.82 CYP1A2 (0.48) SMN1; SMN2KDM4ENPSR1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1342719-A1 Benzodiazepine derivatives useful as CCK-Receptor Antagonists YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-10 EP disclosed
EP-0538945-A1 Benzodiazepine derivatives, and their use as antagonists of gastrin and/or cholecystokinin GLAXO GROUP LIMITED (GB) 1993-04-28 EP disclosed